The BTBD9 gene polymorphisms in Polish patients with Gilles de la Tourette syndrome

• Autorzy: Janik P. , Berdynski M. , Safranow K. , Zekanowski C.
• Języki publikacji: EN

Abstrakty

EN

Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by motor and vocal tics. The etiology of the disorder is unknown, although the predominant role of genetic factors has been established. Variants of the BTBD9 gene (rs4714156, rs9296249 and rs9357271) have been reported to be associated with GTS in French Canadian and Chinese Han populations. Therefore, we decided to test the association between GTS and polymorphisms of the BTBD9 gene in Polish patients. Our cohort of GTS cases comprised 162 patients aged 4-54 years (mean age: 19.9±8.7 years; 131 males, 80.9%). The control group consisted of 180 healthy persons aged 14-55 years (mean age: 23.1±2.1 years; 149 males, 82.8%). The rs4714156, rs9296249 and rs9357271 variants of the BTBD9 gene were genotyped. No significant differences were found in minor allele frequencies (MAFs) of the SNPs tested between the two groups. The frequency of MAFs of the genotyped SNPs was lower in GTS patients with Attention Deficit Hyperactivity Disorder (for rs9357271 and rs9296249, P=0.039 and rs4714156, P=0.040) and higher in GTS patients without comorbidities (for rs9357271 and rs9296249 P=0.021 and rs4714156 P=0.025). There was a trend toward an association between the minor allele of the SNPs and mild tics (P=0.089 for rs9357271 and rs9296249, P=0.057 for rs4714156). Despite limitations of the study, including the small number of cases and analyzed SNPs, our results suggest that the examined BTBD9 variants are not associated with GTS risk, but may be associated with comorbidity and tic severity in the Polish population.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2014
• Tom: 74
• Numer: 2
• Opis fizyczny: p.218-226,ref.

Twórcy

autor

Janik P.

• Department of Neurology, Medical University of Warsaw, Warsaw, Poland

autor

Berdynski M.

• Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

autor

Safranow K.

• Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland

autor

Zekanowski C.

• Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

Bibliografia

• American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. American Psychiatric Association, Arlington, VA.
• Barr CL, Wigg KG, Zovko E, Sandor P, Tsui LC (1996) No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am J Med Genet 67: 301-305.
• Barr CL, Wigg KG, Zovko E, Sandor P, Tsui LC (1997) Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome. Am J Med Genet 74: 58-61.
• Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF (2006) Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 160: 65-69.
• Brett PM, Curtis D, Robertson MM, Gurling HM (1995) The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biol Psychiatry 37: 533-540.
• Brett PM, Curtis D, Robertson MM, Gurling HM (1995) Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Am J Psychiatry 152: 437-440. Burd L, Kerbeshian J, Wikenheiser M, Fisher W (1986) Prevalence of Gilles de la Tourette's syndrome in North Dakota adults. Am J Psychiatry 143: 787-788.
• Cavallini MC, Di Bella D, Catalano M, Bellodi L (2000) An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res 97: 93-100.
• Chou IC, Tsai CH, Lee CC, Kuo HT, Hsu YA, Li CI, Tsai FJ (2004) Association analysis between Tourette's syndrome and dopamine D1 receptor gene in Taiwanese children. Psychiatr Genet 14: 219-221.
• Chou IC, Lin HC, Wang CH, Lin WD, Lee CC, Tsai CH, Tsai FJ (2010) Polymorphisms of interleukin 1 gene IL1RN are associated with Tourette syndrome. Pediatr Neurol 42: 320-324.
• Comings DE, Muhleman D, Dietz G, Dino M, LeGro R, Gade R (1993) Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet 341: 906.
• Comings DE, Gade R, Muhleman D, Chiu C, Wu S, To M, Spence M, Dietz G, Winn-Deen E, Rosenthal RJ, Lesieur HR, Rugle L, Sverd J, Ferry L, Johnson JP, MacMurray JP (1996) Exon and intron variants in the human trypto¬phan 2, 3- dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Pharmacogenetics 6: 307-318.
• Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D (1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes. Am J Med Genet 67: 264-288.
• Cruz C, Camarena B, King N, Paez F, Sidenberg D, de la Fuente JR, Nicolini H (1997) Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorders with tics. Neurosci Lett 231: 1-4.
• de Carvalho Aguiar P, Fazzari M, Jankovic J, Ozelius LJ (2004) Examination of the SGCE gene in Tourette syn¬drome patients with obsessive-compulsive disorder. Mov Disord 19: 1237-1238.
• Devor EJ (1992) The D2 dopamine receptor and Tourette's syndrome. JAMA 267: 651.
• Diaz-Anzaldûa A, Joober R, Rivière JB, Dion Y, Lespérance P, Richer F, Chouinard S, Rouleau GA; Montreal Tourette Syndrome Study Group (2004) Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol Psychiatry 9: 272-277.
• Dickel DE, Veenstra-VanderWeele J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL (2007) Association studies of serotonin system candidate genes in early-onset obessive-compulsive disorder. Biol Psychiatry 61: 322-329.
• Erdmann J, Shimron-Abarbanell D, Cichon S, Albus M, Maier W, Lichtermann D, Minges J, Reuner U, Franzek E, Ertl MA (1995) Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 60: 393-399.
• Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36: 159-165.
• Gade R, Muhleman D, Blake H, MacMurray J, Johnson P, Verde R, Saucier G, Comings DE (1998) Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol Psychiatry 3: 50-60.
• Gadzicki D, Müller-Vahl KR, Heller D, Ossege S, Nöthen MM, Hebebrand J, Stuhrmann M (2004) Tourette syn¬drome is not caused by mutations in the central cannabi- noid receptor (CNR1) gene. Am J Med Genet B Neuropsychiatr Genet 127B: 97-103.
• Gelernter J, Rao PA, Pauls DL, Hamblin MW, Sibley DR, Kidd KK (1995) Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome. Genomics 26: 207-209.
• Gorman DA, Zhu H, Anderson GM, Davies M, Peterson BS (2006) Ferritin levels and their association with regional brain volumes in Tourette's syndrome. Am J Psychiatry 163: 1264-1272.
• Guo Y, Su L, Zhang J, Lei J, Deng X, Xu H,Yang Z, Kuang S, Tang J, Luo Z, Deng H (2012) Analysis of the BTBD9 and HTR2C variants in Chinese Han patients with Tourette syndrome. Psychiatr Genet 22: 300-303.
• Hebebrand J, Nöthen MM, Lehmkuhl G, Poustka F, Schmidt M, Propping P, Remschmidt H (1993) Tourette's syn¬drome and homozygosity for the dopamine D3 receptor gene. Lancet 342: 1483-1484.
• Huang Y, Liu X, Li T, Guo L, Sun X, Xiao X, Ma X, Wang Y, Collier DA (2001) Cases-control association study and transmission disequilibrium test of T102C polymorphism in 5HT2A and Tourette syndrome (in Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18: 11-13.
• Huang Y, Li T, Wang Y, Ansar J, Lanting G, Liu X, Zhao JH, Hu X, Sham PC, Collier D (2004) Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligo- dendrocyte glycoprotein in Tourette's syndrome patients from a Chinese sample. Am J Med Genet B Neuropsychiatr Genet 124B: 76-80.
• Janik P, Kalbarczyk A, Sitek M (2007) Clinical analysis of Gilles de la Tourette syndrome based on 126 cases. Neurol Neurochir Pol 41: 381-387.
• Jones BC, Reed CL, Hitzemann R,Wiesinger JA, McCarthy KA, Buwen JP, Beard JL (2003) Quantitative genetic analysis of ventral midbrain and liver iron in BXD recombinant inbred mice. Nutr Neurosci 6: 369-377.
• Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS (1998) Course of tic severity in Tourette's syndrome: The first two decades. Pediatrics 102: 234-245.
• Lee CC, Chou IC, Tsai CH, Wang TR, Li TC, Tsai FJ (2005) Dopamine receptor D2 gene polymorphisms are associ¬ated in Taiwanese children with Tourette syndrome. Pediatr Neurol 33: 272-276.
• Lei J, Deng X, Zhang J, Su L, Xu H, Liang H, Huang X, Song Z, Deng H (2012) Mutation screening of the HDC gene in Chinese Han patients with Tourette syndrome. Am J Med Genet Part B 159B: 72-76.
• Niesler B, Frank B, Hebebrand J, Rappold G (2005) Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatr Genet 15: 303-304.
• Noble EP (2000) The DRD2 gene in psychiatric and neuro¬logical disorders and its phenotypes. Pharmacogenomics 1: 309-333.
• Ozbay F, Wigg KG, Turanli ET, Asherson P, Yazgan Y, Sandor P, Barr CL (2006) Analysis of the dopamine beta hydroxylase gene in Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 141B: 673-677.
• Riviere JB, Xiong L, Levchenko A, St-Onge J, Gaspar C, Dion Y, Lesperance P, Tellier G, Richer F, Chouinard S, Rouleau GA, Montreal Tourette Study Group (2009) Association of intronic variants of the BTBD9 gene with Tourette syndrome. Arch Neurol 66: 1267-1272.
• Robertson MM (2008) The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 65: 473-486.
• Rowe DC, Stever C, Gard JM, Cleveland HH, Sanders ML, Abramowitz A, Kozol ST, Mohr JH, Sherman SL, Waldman ID (1998) The relation of the dopamine trans¬porter gene (DAT1) to symptoms of internalizing disor¬ders in children. Behav Genet 28: 215-225.
• Schoenian S, Konig I, Oertel W, Remschmidt H, Ziegler A, Hebebrand J, Bandmann O (2003) HLA-DRB genotyping in Gilles de la Tourette patients and their parents. Am J Med Genet B Neuropsychiatr Genet 119B: 60-64.
• Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S (1999) The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56: 842-847.
• Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Prive GG (2005) Sequence and structural analysis of BTB domain proteins. Genome Biol 6: R82.
• Tarnok Z, Ronai Z, Gervai J, Kereszturi E, Gadoros J, Sasvari-Szekely M, Nemoda Z (2007) Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3'UTR polymorphism of dop¬amine transporter gene. Am J Med Genet B Neuropsychiatr Genet 144B: 900-905.
• Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Pütz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39: 1000-1006.
• Yoon DY, Rippel CA, Kobets AJ, Morris CM, Lee JE, Williams PN, Bridges DD, Vandenbergh DJ, Shugart YY, Singer HS (2007) Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 144B: 605-610.